DexCom (DXCM) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
DexCom (DXCM) PT Lowered to $105 at Oppenheimer; 'Buying on Weakness'
July 29, 2022 7:25 AM EDTOppenheimer analyst Steven Lichtman lowered the price target on DexCom (NASDAQ: DXCM) to $105.00 (from $525.00) while maintaining an Outperform rating following weak results. The analyst is buying on weakness.
The analyst commented, "DexCom's 2Q22 sales of $696.2M (+17% y/y) slightly lagged our/Street's... More
